Cargando…

Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”

Detalles Bibliográficos
Autores principales:	Filidou, Eirini, Kolios, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222977/ https://www.ncbi.nlm.nih.gov/pubmed/37242497 http://dx.doi.org/10.3390/ph16050714

Ejemplares similares

Systems biology in inflammatory bowel diseases: on the way to precision medicine
por: Dovrolis, Nikolas, et al.
Publicado: (2019)

Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface
por: Valatas, Vassilis, et al.
Publicado: (2017)

Special Issue: Microbiota–Gut–Brain Axis
por: Obrenovich, Mark, et al.
Publicado: (2022)

Editorial of the Special Issue “Dietary Fiber and Inflammatory Bowel Disease”
por: Liu, Gang, et al.
Publicado: (2022)

Probiotics in Intestinal Mucosal Healing: A New Therapy or an Old Friend?
por: Filidou, Eirini, et al.
Publicado: (2021)

Special Issue: The Role of Gut Microbiota in Gastrointestinal Cancers—From Pathogenesis to Therapeutic Perspectives
por: Niikura, Ryota
Publicado: (2023)

Special Issue “Nutritional Regulation on Gut Microbiota”: Editorial
por: Shen, Garry X.
Publicado: (2023)

Special Issue “Gastrointestinal Microbiota and Gut Barrier Impact Human Health and Disease”: Editorial
por: Raoul, Pauline, et al.
Publicado: (2023)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?
por: Dovrolis, Nikolas, et al.
Publicado: (2022)

The Length of Surgical Skin Incision in Postoperative Inflammatory Reaction
por: Ioannidis, Aristidis, et al.
Publicado: (2018)

Inflammatory Bowel Diseases and Gut Microbiota
por: Haneishi, Yuri, et al.
Publicado: (2023)

Gut Microbiota in Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2013)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Special issue on neurodegenerative diseases and their therapeutic approaches
por: Kim, Jungsu, et al.
Publicado: (2015)

Editorial of Special Issues “Gut Microbiota–Host Interactions: From Symbiosis to Dysbiosis 2.0”
por: Zuccaro, Valentina, et al.
Publicado: (2023)

Microorganisms Special Issue “How Do Food and Probiotics Influence the Composition and Activity of the Gut Microbiota?”
por: LaPointe, Gisèle, et al.
Publicado: (2022)

Editorial for Special Issue “Lipid as a Cancer Therapeutic Target”
por: Albi, Elisabetta, et al.
Publicado: (2021)

Special Issue: Gut Bacteria-Mucus Interaction
por: Juge, Nathalie
Publicado: (2019)

Special Issue on the “Regulation and Physiopathology of the Gut Barrier”
por: Thenet, Sophie, et al.
Publicado: (2022)

Special issue on therapeutic antibodies and biopharmaceuticals
por: Chung, Junho
Publicado: (2017)

Special Issue “Bifidobacteria: Insights from Ecology to Genomics of a Key Microbial Group of the Mammalian Gut Microbiota”
por: Ventura, Marco, et al.
Publicado: (2020)

Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review
por: Koutouratsas, Tilemachos, et al.
Publicado: (2021)

Editorial for the Special Issue: Gut Microorganisms of Aquatic Animals
por: Kormas, Konstantinos Ar.
Publicado: (2019)

Gut Feelings: The Psychological Impact of Inflammatory Bowel Disease
por: Caballero-Mateos, Antonio M
Publicado: (2023)

Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
por: Alshehri, Dikhnah, et al.
Publicado: (2021)

Editorial: Special Issue—Understanding and Targeting Heart Failure: From Biology to Therapeutics
por: Pu, Jun, et al.
Publicado: (2023)

Special Issue “Gut Microbioma Structure and Functions in Human Health and Disease”: Editorial
por: Di Pierro, Francesco
Publicado: (2023)

Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
por: Nishida, Atsushi, et al.
Publicado: (2021)

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids
por: Raup-Konsavage, Wesley M.
Publicado: (2023)

Special Issue: Cancer Metastasis and Therapeutic Resistance
por: Yeh, Elizabeth S.
Publicado: (2023)

The gut microbiota in mouse models of inflammatory bowel disease
por: Gkouskou, Kalliopi K., et al.
Publicado: (2014)

Diet and microbiota in inflammatory bowel disease: The gut in disharmony
por: Rapozo, Davy C M, et al.
Publicado: (2017)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
por: Hu, Yongjia, et al.
Publicado: (2022)

Microbiota Alterations in Inflammatory Bowel Diseases: From Correlation to Causality
por: Chassaing, Benoit
Publicado: (2016)

Special Issue “The Role of Mesenchymal Stem Cells on Inflammatory and Fibrotic Diseases”
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

Special Issue: Hypertensive Heart Disease—From Pathophysiology to Therapeutical Challenges
por: Vischer, Annina S., et al.
Publicado: (2022)

Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells
por: Filidou, Eirini, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5lmr5q6vt4506rmk6lc09kn1rl